Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model

Addiction

Volumn 112, Issue 3, 2017, Pages 401-412

  Mathew, Amanda R ^a   Hogarth, Lee ^b   Leventhal, Adam M ^c   Cook, Jessica W ^d,e   Hitsman, Brian ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Depression; nicotine dependence; review; smoking; smoking cessation; treatment

Indexed keywords

CIGARETTE SMOKING; COMORBIDITY; DEPRESSION; HUMAN; PSYCHOLOGY; SMOKING; THEORETICAL MODEL;

CIGARETTE SMOKING; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; MODELS, THEORETICAL; SMOKING;

EID: 84996528828     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13604     Document Type: Review

References (163)

1. Grant B. F., Hasin D. S., Chou S. P., Stinson F. S., Dawson D. A. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2004; 61: 1107–1115.
2. Hall S. M., Prochaska J. J. Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psychol 2009; 5: 409–431.
3. Lasser K., Boyd J. W., Woolhandler S., Himmelstein D. U., McCormick D., Bor D. H. Smoking and mental illness: a population-based prevalence study. JAMA 2000; 284: 2606–2610.
4. Lawrence D., Mitrou F., Zubrick S. R. Smoking and mental illness: results from population surveys in Australia and the United States. BMC. Public Health 2009; 9: 285.
5. Ziedonis D., Hitsman B., Beckham J. C., Zvolensky M., Adler L. E., Audrain-McGovern J. et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res 2008; 10: 1691–1715.
6. Cook B. L., Wayne G. F., Kafali E. N., Liu Z., Shu C., Flores M. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA 2014; 311: 172–182.
7. Breslau N., Kilbey M. M., Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry 1992; 149: 464–469.
8. Weinberger A. H., Desai R. A., McKee S. A. Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disorders. Drug Alcohol Depend 2010; 108: 7–12.
9. Goodwin R. D., Zvolensky M. J., Keyes K. M., Hasin D. S. Mental disorders and cigarette use among adults in the United States. Am J Addict 2012; 21: 416–423.
10. Grant B. F., Hasin D. S., Chou S., Stinson F. S., Dawson D. A. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and relatedconditions. Arch Gen Psychiatry 2004; 61: 1107–1115.
11. Khaled S. M., Bulloch A., Exner D. V., Patten S. B. Cigarette smoking, stages of change, and major depression in the Canadian population. Can J Psychiatry 2009; 54: 204–208.
12. Khaled S. M., Bulloch A. G., Williams J. V., Lavorato D. H., Patten S. B. Major depression is a risk factor for shorter time to first cigarette irrespective of the number of cigarettes smoked per day: evidence from a national population health survey. Nicotine Tob Res 2011; 13: 1059–1067.
13. Acton G. S., Kunz J. D., Wilson M., Hall S. M. The construct of internalization: conceptualization, measurement, and prediction of smoking treatment outcome. Psychol Med 2005; 35: 395–408.
14. Prochaska J. J., Rossi J. S., Redding C. A., Rosen A. B., Tsoh J. Y., Humfleet G. L. et al. Depressed smokers and stage of change: implications for treatment interventions. Drug Alcohol Depend 2004; 76: 143–151.
15. Buckner J. D., Farris S. G., Zvolensky M. J., Shah S. M., Leventhal A. M., Minnix J. A. et al. Dysphoria and smoking among treatment seeking smokers: the role of smoking-related inflexibility/avoidance. Am J Drug Alcohol Abuse 2015; 41: 45–51.
16. Cooper J., Borland R., McKee S. A., Yong H. H., Dugué P. A. Depression motivates quit attempts but predicts relapse: differential findings for gender from the International Tobacco Control study. Addiction 2016; 111: 1438–1447.
17. Williams J. M., Stroup T. S., Brunette M. F., Raney L. E. Integrated care: tobacco use and mental illness: a wake-up call for psychiatrists. Psychiatr Serv 2014; DOI: 10.1176/appi.ps.201400235.
18. Druss B. G., Zhao L., Von Esenwein S., Morrato E. H., Marcus S. C. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care 2011; 49: 599–604.
19. Colton C., Manderscheid R. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006; 3: A42.
20. Tiihonen J., Lönnqvist J., Wahlbeck K., Klaukka T., Niskanen L., Tanskanen A. et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study fin11 study. Lancet 2009; 374: 620–627.
21. Kahler C. W., Spillane N. S., Busch A. M., Leventhal A. M. Time-varying smoking abstinence predicts lower depressive symptoms following smoking cessation treatment. Nicotine Tob Res 2011; 13: 146–150.
22. Mathew A. R., Robinson J. D., Norton P. J., Cinciripini P. M., Brown R. A., Blalock J. A. Affective trajectories before and after a quit attempt among smokers with current depressive disorders. Nicotine Tob Res 2013; 15: 1807–1815.
23. Taylor G., McNeill A., Girling A., Farley A., Lindson-Hawley N., Aveyard P. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 2014; 348: g1151.
24. Berlin I., Chen H., Covey L. S. Depressive mood, suicide ideation and anxiety in smokers who do and smokers who do not manage to stop smoking after a target quit day. Addiction 2010; 105: 2209–2216.
25. McDermott M. S., Marteau T. M., Hollands G. J., Hankins M., Aveyard P. Change in anxiety following successful and unsuccessful attempts at smoking cessation: cohort study. Br J Psychiatry 2013; 202: 62–67.
26. Bakhshaie J., Zvolensky M. J., Goodwin R. D. Cigarette smoking and the onset and persistence of depression among adults in the United States: 1994–2005. Compr Psychiatry 2014; DOI: 10.1016/j.comppsych.2014.10.012.
27. US Department of Health and Human Services (USDHHS). The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: USDHHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
28. Bowins B. Depression: discrete or continuous? Psychopathology 2015; 48: 69–78.
29. Angst J., Sellar R., Merikangas K. R. Depressive spectrum diagnoses. Compr Psychiatry 2000; 41: 39–47.
30. Ayuso-Mateos J. L., Nuevo R., Verdes E., Naidoo N., Chatterji S. From depressive symptoms to depressive disorders: the relevance of thresholds. Br J Psychiatry 2010; 196: 365–371.
31. Anthenelli R. M., Morris C., Ramey T. S., Dubrava S. J., Tsilkos K., Russ C. et al. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Intern Med 2013; 159: 390–400.
32. Dickinson A., Balleine B. W. The cognitive/motivational interface. In: Kringelbach M. L., Berridge K. C., editors. Pleasures of the Brain. The Neural Basis of Taste, Smell and Other Rewards. Oxford, UK: Oxford University Press; 2010, pp. 74–84.
33. Balleine B. W., Ball J., Dickinson A. Benzodiazepine-induced outcome revaluation and the motivational control of instrumental action in rats. Behav Neurosci 1994; 108: 573–589.
34. Heyes C., Dickinson A. The intentionality of animal action. Mind Lang 1990; 5: 87–103.
35. Pittenger S. T., Bevins R. A. Interoceptive conditioning with a nicotine stimulus is susceptible to reinforcer devaluation. Behav Neurosci 2013; 127: 465–473.
36. Bradfield L. A., Balleine B. W. Hierarchical and binary associations compete for behavioral control during instrumental biconditional discrimination. J Exp Psychol Anim Behav Process 2013; 39: 2–13.
37. Trask S., Bouton M. Contextual control of operant behavior: Evidence for hierarchical associations in instrumental learning. Learn Behav 2014; 42: 281–288.
38. Hogarth L., Troisi J. R. 2nd. A hierarchical instrumental decision theory of nicotine dependence. In: Balfour D. J. K., Munafò M. R., editors. The Neurobiology and Genetics of Nicotine and Tobacco. Current Topics in Behavioral Neurosciences. Gewerbestrasse, Switzerland: Springer International Publishing; 2015, pp. 165–191.
39. Hogarth L., Retzler C., Munafò M. R., Tran D. M. D., Troisi J. R. 2nd, Rose A. K. et al. Extinction of cue-evoked drug-seeking relies on degrading hierarchical instrumental expectancies. Behav Res Ther 2014; 59: 61–70.
40. Hogarth L., He Z., Chase H. W., Wills A. J., Troisi J. R. 2nd, Leventhal A. M. et al. Negative mood reverses devaluation of goal-directed drug-seeking favouring an incentive learning account of drug dependence. Psychopharmacology (Berl) 2015; 232: 3235–3247.
41. ®). Arlington, VA: American Psychiatric Publishers; 2013.
42. Leventhal A. M., Ramsey S. E., Brown R. A., LaChance H. R., Kahler C. W. Dimensions of depressive symptoms and smoking cessation. Nicotine Tob Res 2008; 10: 507–517.
43. Haas A. L., Munoz R. F., Humfleet G. L., Reus V. I., Hall S. M. Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clin Psychol 2004; 72: 563–570.
44. Watson D., Clark L. A., Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988; 54: 1063.
45. Watson D., Weber K., Assenheimer J. S., Clark L. A., Strauss M. E., McCormick R. A. Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. J Abnorm Psychol 1995; 104: 3–14.
46. Leventhal A. M., Kahler C. W., Ray L. A., Zimmerman M. Refining the depression–nicotine dependence link: patterns of depressive symptoms in psychiatric outpatients with current, past, and no history of nicotine dependence. Addict Behav 2009; 34: 297–303.
47. Mickens L., Greenberg J., Ameringer K. J., Brightman M., Sun P., Leventhal A. M. Associations between depressive symptom dimensions and smoking dependence motives. Eval Health Prof 2011; 34: 81–102.
48. Leventhal A. M., Zvolensky M. J., Schmidt N. B. Smoking-related correlates of depressive symptom dimensions in treatment-seeking smokers. Nicotine Tob Res 2011; 13: 668–676.
49. Leventhal A. M., Piper M. E., Japuntich S. J., Baker T. B., Cook J. W. Anhedonia, depressed mood, and smoking cessation outcome. J Consult Clin Psychol 2014; 82: 122–129.
50. Cook J., Spring B., McChargue D., Doran N. Effects of anhedonia on days to relapse among smokers with a history of depression: a brief report. Nicotine Tob Res 2010; 12: 978–982.
51. Cook J. W., Piper M. E., Leventhal A. M., Schlam T. R., Fiore M. C., Baker T. B. Anhedonia as a component of the tobacco withdrawal syndrome. J Abnorm Psychol 2015; 124: 215–225.
52. Hitsman B., Pingitore R., Spring B., Mahableshwarkar A., Mizes J. S., Segraves K. A. et al. Antidepressant pharmacotherapy helps some cigarette smokers more than others. J Consult Clin Psychol 1999; 67: 547–554.
53. Schnoll R. A., Leone F. T., Hitsman B. Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patch. J Addict Dis 2013; 32: 46–52.
54. Clark L. A., Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol 1991; 100: 316–336.
55. Elliot A. J., Thrash T. M. Approach–avoidance motivation in personality: approach and avoidance temperaments and goals. J Pers Soc Psychol 2002; 82: 804–818.
56. Lane R. D., Reiman E. M., Bradley M. M., Lang P. J., Ahern G. L., Davidson R. J. et al. Neuroanatomical correlates of pleasant and unpleasant emotion. Neuropsychologia 1997; 35: 1437–1444.
57. Leventhal A. M., Zvolensky M. J. Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychol Bull 2015; 141: 176–212.
58. Audrain-McGovern J., Wileyto E. P., Ashare R., Cuevas J., Strasser A. A. Reward and affective regulation in depression-prone smokers. Biol Psychiatry 2014; 76: 689–697.
59. Pergadia M. L., Der-Avakian A., D'Souza M. S., Madden P. A., Heath A. C., Shiffman S. et al. Association between nicotine withdrawal and reward responsiveness in humans and rats. JAMA Psychiatry 2014; 71: 1238–1245.
60. Dawkins L., Powell J. H., West R., Powell J., Pickering A. A double-blind placebo controlled experimental study of nicotine: I—effects on incentive motivation. Psychopharmacology (Berl) 2006; 189: 355–367.
61. Cook J. W., Spring B., McChargue D. Influence of nicotine on positive affect in anhedonic smokers. Psychopharmacology (Berl) 2007; 192: 87–95.
62. Perkins K. A., Karelitz J. L. Reinforcement enhancing effects of nicotine via smoking. Psychopharmacology (Berl) 2013; 228: 479–486.
63. Leventhal A. M., Waters A. J., Moolchan E. T., Heishman S. J., Pickworth W. B. A quantitative analysis of subjective, cognitive, and physiological manifestations of the acute tobacco abstinence syndrome. Addict Behav 2010; 35: 1120–1130.
64. Leventhal A. M., Munafo M., Tidey J. W., Sussman S., Monterosso J. R., Sun P. et al. Anhedonia predicts altered processing of happy faces in abstinent cigarette smokers. Psychopharmacology (Berl) 2012; 222: 343–351.
65. Leventhal A., Trujillo M., Ameringer K., Tidey J., Sussman S., Kahler C. Anhedonia and the relative reward value of drug and nondrug reinforcers in cigarette smokers. J Abnorm Psychol 2014; 123: 375–386.
66. Leventhal A. M., Waters A. J., Kahler C. W., Ray L. A., Sussman S. Relations between anhedonia and smoking motivation. Nicotine Tob Res 2009; 11: 1047–1054.
67. Cook J. W., Spring B., McChargue D., Hedeker D. Hedonic capacity, cigarette craving, and diminished positive mood. Nicotine Tob Res 2004; 6: 39–47.
68. Baker T. B., Piper M. E., McCarthy D. E., Majeskie M. R., Fiore M. C. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev 2004; 111: 33–51.
69. Balfour D. J., Ridley D. L. The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction? Pharmacol Biochem Behav 2000; 66: 79–85.
70. Tizabi Y., Overstreet D. H., Rezvani A. H., Louis V. A., Clark E. Jr., Janowsky D. S. et al. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology (Berl) 1999; 142: 193–199.
71. Vázquez-Palacios G., Bonilla-Jaime H., Velázquez-Moctezuma J. Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 39–46.
72. Mineur Y. S., Picciotto M. R. Biological basis for the co-morbidity between smoking and mood disorders. J Dual Diagn 2009; 5: 122–130.
73. Heckman B. W., Carpenter M. J., Correa J. B., Wray J. M., Saladin M. E., Froeliger B. et al. Effects of experimental negative affect manipulations on ad libitum smoking: a meta-analysis. Addiction 2015; 110: 751–760.
74. Hatsukami D. K., Hughes J. R., Pickens R. W., Svikis D. Tobacco withdrawal symptoms: an experimental analysis. Psychopharmacology (Berl) 1984; 84: 231–236.
75. Hughes J. R., Hatsukami D. K., Pickens R. W., Krahn D., Malin S., Luknic A. Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology (Berl) 1984; 83: 82–87.
76. Parrott A. C. Stress modulation over the day in cigarette smokers. Addiction 1995; 90: 233–244.
77. Perkins K. A., Karelitz J. L., Conklin C. A., Sayette M. A., Giedgowd G. E. Acute negative affect relief from smoking depends on the affect situation and measure but not on nicotine. Biol Psychiatry 2010; 67: 707–714.
78. Perkins K. A., Ciccocioppo M., Conklin C. A., Milanak M. E., Grottenthaler A., Sayette M. A. Mood influences on acute smoking responses are independent of nicotine intake and dose expectancy. J Abnorm Psychol 2008; 117: 79.
79. Conklin C. A., Perkins K. A. Subjective and reinforcing effects of smoking during negative mood induction. J Abnorm Psychol 2005; 114: 153–164.
80. Kassel J. D., Shiffman S. Attentional mediation of cigarette smoking's effect on anxiety. Health Psychol 1997; 16: 359–368.
81. Kassel J. D., Unrod M. Smoking, anxiety, and attention: support for the role of nicotine in attentionally mediated anxiolysis. J Abnorm Psychol 2000; 109: 161–166.
82. Willner P., Jones C. Effects of mood manipulation on subjective and behavioural measures of cigarette craving. Behav Pharmacol 1996; 7: 355–363.
83. Hughes J. R. Effects of abstinence from tobacco: Etiology, animal models, epidemiology, and significance: a subjective review. Nicotine Tob Res 2007; 9: 329–339.
84. Piper M. E. Withdrawal: Expanding a key addiction construct. Nicotine Tob Res 2015; 17: 1405–1415.
85. Leventhal A. M., Ameringer K. J., Osborn E., Zvolensky M. J., Langdon K. J. Anxiety and depressive symptoms and affective patterns of tobacco withdrawal. Drug Alcohol Depend 2013; 133: 324–329.
86. Gilbert D. G., McClernon F. J., Rabinovich N. E., Dibb W. D., Plath L. C., Hiyane S. et al. EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: relations to depressive traits, nicotine exposure, and dependence. Exp Clin Psychopharmacol 1999; 7: 427–443.
87. Audrain-McGovern J., Wileyto E. P., Ashare R., Cuevas J., Strasser A. A. Reward and affective regulation in depression-prone smokers. Biol Psychiatry 2014; 76: 689–697.
88. Lerman C., Audrain J., Orleans C. T., Boyd R., Gold K., Main D. et al. Investigation of mechanisms linking depressed mood to nicotine dependence. Addict Behav 1996; 21: 9–19.
89. Brody C. L., Hamer D. H., Haaga D. A. Depression vulnerability, cigarette smoking, and the serotonin transporter gene. Addict Behav 2005; 30: 557–566.
90. Bora E., Harrison B., Yücel M., Pantelis C. Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med 2013; 43: 2017–2026.
91. Trivedi M. H., Greer T. L. Cognitive dysfunction in unipolar depression: implications for treatment. J Affect Disord 2014; 152–154: 19–27.
92. Hammar A., Ardal G. Cognitive functioning in major depression—a summary. Front Hum Neurosci 2009; 3: 26.
93. Lee R. S., Hermens D. F., Porter M. A., Redoblado-Hodge M. A. A meta-analysis of cognitive deficits in first-episode major depressive disorder. J Affect Disord 2012; 140: 113–124.
94. Murrough J. W., Iacoviello B., Neumeister A., Charney D. S., Iosifescu D. V. Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies. Neurobiol Learn Mem 2011; 96: 553–563.
95. Austin M.-P., Mitchell P., Goodwin G. M. Cognitive deficits in depression possible implications for functional neuropathology. Br J Psychiatry 2001; 178: 200–206.
96. Millan M. J., Agid Y., Brüne M., Bullmore E. T., Carter C. S., Clayton N. S. et al. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 2012; 11: 141–168.
97. McIntyre R. S., Cha D. S., Soczynska J. K., Woldeyohannes H. O., Gallaugher L. A., Kudlow P. et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety 2013; 30: 515–527.
98. Evans V. C., Chan S. S., Iverson G. L., Bond D. J., Yatham L. N., Lam R. W. Systematic review of neurocognition and occupational functioning in major depressive disorder. Neuropsychiatry 2013; 3: 97–105.
99. Buist-Bouwman M., Ormel J., de Graaf R., de Jonge P., van Sonderen E., Alonso J. et al. Mediators of the association between depression and role functioning. Acta Psychiatr Scand 2008; 118: 451–458.
100. Jaeger J., Berns S., Uzelac S., Davis-Conway S. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res 2006; 145: 39–48.
101. Jacobsen L. K., Krystal J. H., Mencl W. E., Westerveld M., Frost S. J., Pugh K. R. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry 2005; 57: 56–66.
102. Jacobsen L. K., Mencl W. E., Constable R. T., Westerveld M., Pugh K. R. Impact of smoking abstinence on working memory neurocircuitry in adolescent daily tobacco smokers. Psychopharmacology (Berl) 2007; 193: 557–566.
103. Mendrek A., Monterosso J., Simon S. L., Jarvik M., Brody A., Olmstead R. et al. Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence. Addict Behav 2006; 31: 833–844.
104. McClernon F. J., Addicott M. A., Sweitzer M. M. Smoking abstinence and neurocognition: implications for cessation and relapse. Curr Top Behav Neurosci 2015; 23: 193–227.
105. Freeman T. P., Morgan C. J., Beesley T., Curran H. V. Drug cue induced overshadowing: selective disruption of natural reward processing by cigarette cues amongst abstinent but not satiated smokers. Psychol Med 2012; 42: 161–171.
106. Waters A. J., Carter B. L., Robinson J. D., Wetter D. W., Lam C. Y., Kerst W. et al. Attentional bias is associated with incentive-related physiological and subjective measures. Exp Clin Psychopharmacol 2009; 17: 247–257.
107. Canamar C. P., London E. Acute cigarette smoking reduces latencies on a smoking Stroop test. Addict Behav 2012; 37: 627–631.
108. Ashare R., Strasser A. A., Wileyto E. P., Cuevas J., Audrain-McGovern J. Cognitive deficits specific to depression-prone smokers during abstinence. Exp Clin Psychopharmacol 2014; 22: 323–331.
109. Hartlage S., Alloy L. B., Vázquez C., Dykman B. Automatic and effortful processing in depression. Psychol Bull 1993; 113: 247–278.
110. Gotlib I. H., Joormann J. Cognition and depression: current status and future directions. Annu Rev Clin Psychol 2010; 6: 285–312.
111. Patterson F., Jepson C., Loughead J., Perkins K., Strasser A. A., Siegel S. et al. Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend 2010; 106: 61–64.
112. Powell J., Dawkins L., West R., Powell J., Pickering A. Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology (Berl) 2010; 212: 537–549.
113. Kassel J. D., Yates M., Brown R. A. Baseline reaction time predicts 12-month smoking cessation outcome in formerly depressed smokers. Psychol Addict Behav 2007; 21: 415–419.
114. Malpass D., Higgs S. How is cigarette smoking maintained in depression? Experiences of cigarette smoking in people diagnosed with depression. Addict Res Theory 2009; 17: 64–79.
115. Malpass D., Higgs S. Acute psychomotor, subjective and physiological responses to smoking in depressed outpatient smokers and matched controls. Psychopharmacology (Berl) 2007; 190: 363–372.
116. Skinner B. F. The Behavior of Organisms: An Experimental Analysis. Oxford, UK: Appleton-Century; 1938.
117. Pomerleau O. F., Pomerleau C. S. Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation. Neurosci Biobehav Rev 1984; 8: 503–513.
118. Carmody T. P. Affect regulation, tobacco addiction, and smoking cessation. J Psychoact Drugs 1989; 21: 331–342.
119. Baker T. B., Piper M. E., McCarthy D. E., Majeskie M. R., Fiore M. C. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev 2004; 111: 33–51.
120. Koob G. F. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009; 56: 18–31.
121. Koob G. F., Volkow N. D. Neurocircuitry of addiction. Neuropsychopharmacology 2010; 35: 217–238.
122. Belin D., Belin-Rauscent A., Murray J. E., Everitt B. J. Addiction: failure of control over maladaptive incentive habits. Curr Opin Neurobiol 2013; 23: 564–572.
123. Hull C. L. Principles of Behavior. New York: Appleton-Century-Crofts; 1943.
124. Miles F. J., Everitt B. J., Dickinson A. Oral cocaine seeking by rats: action or habit? Behav Neurosci 2003; 117: 927–938.
125. Dickinson A., Wood N., Smith J. W. Alcohol seeking by rats: action or habit? Q J Exp Psychol B 2002; 55: 331–348.
126. Corbit L. H., Nie H., Janak P. H. Habitual alcohol seeking: time course and the contribution of subregions of the dorsal striatum. Biol Psychiatry 2012; 72: 389–395.
127. Dougher M. J., Hackbert L. Establishing operations, cognition, and emotion. Behav Anal 2000; 23: 11–24.
128. Michael J. Establishing operations. Behav Anal 1993; 16: 191–206.
129. Laraway S., Snycerski S., Olson R., Becker B., Poling A. The motivating operations concept: current status and critical response. Psychol Rec 2014; 64: 601–623.
130. Troisi J. R. 2nd. Sensation within the skin. ACS Chem Neurosci 2015; 6: 209–210.
131. Spring B., Pingitore R., McChargue D. E. Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers. Am J Psychiatry 2003; 160: 316–322.
132. Audrain-McGovern J., Wileyto E. P., Ashare R., Cuevas J., Strasser A. A. Reward and affective regulation in depression-prone smokers. Biol Psychiatry 2014; 76: 689–697.
133. Leventhal A. M., Trujillo M., Ameringer K. J., Tidey J. W., Sussman S., Kahler C. W. Anhedonia and the relative reward value of drug and nondrug reinforcers in cigarette smokers. J Abnorm Psychol 2014; 123: 375–386.
134. Brandon T. H., Wetter D. W., Baker T. B. Affect, expectancies, urges and smoking: do they conform to models of drug motivation and relapse? Exp Clin Psychopharmacol 1996; 4: 29–36.
135. Perkins K. A., Karelitz J. L., Giedgowd G. E., Conklin C. A. Negative mood effects on craving to smoke in women versus men. Addict Behav 2013; 38: 1527–1531.
136. Vinci C., Copeland A. L., Carrigan M. H. Exposure to negative affect cues and urge to smoke. Exp Clin Psychopharmacol 2012; 20: 47–55.
137. Payne T. J., Schare M. L., Levis D. J., Colletti G. Exposure to smoking-relevant cues: Effects on desire to smoke and topographical components of smoking behaviour. Addict Behav 1991; 16: 467–479.
138. Fucito L. M., Juliano L. M., Toll B. A. Cognitive reappraisal and expressive suppression emotion regulation strategies in cigarette smokers. Nicotine Tob Res 2010; 12: 1156–1161.
139. Hitsman B., Spring B., Pingitore R., Munafò M., Hedeker D. Effect of tryptophan depletion on the attentional salience of smoking cues. Psychopharmacology (Berl) 2007; 192: 317–324.
140. Dennett D. C. Content and Consciousness. London, UK: Routledge; 2010.
141. Wiers R. W., Gladwin T. E., Hofmann W., Salemink E., Ridderinkhof K. R. Cognitive bias modification and cognitive control training in addiction and related psychopathology mechanisms, clinical perspectives, and ways forward. Clin Psychol Sci 2013; DOI: 10.1177/2167702612466547.
142. Rhodes J. D., Hawk L. W. Jr., Ashare R. L., Schlienz N. J., Mahoney M. C. The effects of varenicline on attention and inhibitory control among treatment-seeking smokers. Psychopharmacology (Berl) 2012; 223: 131–138.
143. Mocking R. J., Patrick Pflanz C., Pringle A., Parsons E., McTavish S. F., Cowen P. J. et al. Effects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, study. Neuropsychopharmacology 2013; 38: 476–484.
144. Patterson F., Jepson C., Strasser A. A., Loughead J., Perkins K. A., Gur R. C. et al. Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry 2009; 65: 144–149.
145. Lerman C., Niaura R., Collins B. N., Wileyto P., Audrain-McGovern J., Pinto A. et al. Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Psychol Addict Behav 2004; 18: 362–366.
146. Catley D., Harris K. J., Okuyemi K. S., Mayo M. S., Pankey E., Ahluwalia J. S. The influence of depressive symptoms on smoking cessation among african americans an a randomized trial of bupropion. Nicotine Tob Res 2005; 7: 859–870.
147. Niaura R., Britt D. M., Shadel W. G., Goldstein M., Abrams D., Brown R. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav 2001; 15: 13–17.
148. Piper M. E., Smith S. S., Schlam T. R., Fiore M. C., Jorenby D. E., Fraser D. et al. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry 2009; 66: 1253–1262.
149. Smith S. S., McCarthy D. E., Japuntich S. J., Christiansen B., Piper M. E., Jorenby D. E. et al. Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med 2009; 169: 2148–2155.
150. Ebbert J. O., Hatsukami D. K., Croghan I. T., Schroeder D. R., Allen S. S., Hays J. T. et al. Combination varenicline and bupropion sr for tobacco-dependence treatment in cigarette smokers: a randomized trial. JAMA 2014; 311: 155–163.
151. Brown R. A., Kahler C. W., Niaura R., Abrams D. B., Sales S. D., Ramsey S. E. et al. Cognitive–behavioral treatment for depression in smoking cessation. J Consult Clin Psychol 2001; 69: 471–480.
152. Brown R. A., Niaura R., Lloyd-Richardson E. E., Strong D. R., Kahler C. W., Abrantes A. M. et al. Bupropion and cognitive–behavioral treatment for depression in smoking cessation. Nicotine Tob Res 2007; 9: 721–730.
153. Gierisch J. M., Bastian L. A., Calhoun P. S., McDuffie J. R., Williams J. W. Jr. Smoking cessation interventions for patients with depression: a systematic review and meta-analysis. J Gen Intern Med 2012; 27: 351–360.
154. van der Meer R. M., Willemsen M. C., Smit F., Cuijpers P. Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev 2013; Issue 8. Art. No.: CD006102. DOI: 10.1002/14651858.CD006102.pub2.
155. Dimidjian S., Hollon S. D., Dobson K. S., Schmaling K. B., Kohlenberg R. J., Addis M. E. et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol 2006; 74: 658–670.
156. MacPherson L., Tull M. T., Matusiewicz A. K., Rodman S., Strong D. R., Kahler C. W. et al. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clin Psychol 2010; 78: 55–61.
157. Kassel J. D., Stroud L. R., Paronis C. A. Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol Bull 2003; 129: 270–304.
158. Brandon T. H. Negative affect as motivation to smoke. Curr Dir Psychol Sci 1994; 3: 33–37.
159. Piper M. E., Rodock M., Cook J. W., Schlam T. R., Fiore M. C., Baker T. Psychiatric diagnoses among quitters versus continuing smokers 3 years after their quit day. Drug Alcohol Depend 2013; 128: 148–154.
160. Hall F. S., Der-Avakian A., Gould T. J., Markou A., Shoaib M., Young J. W. Negative affective states and cognitive impairments in nicotine dependence. Neurosci Biobehav Rev 2015; 58: 168–185.
161. McClave A. K., Dube S. R., Strine T. W., Kroenke K., Caraballo R. S., Mokdad A. H. Associations between smoking cessation and anxiety and depression among U.S. Adults. Addict Behav 2009; 34: 491–497.
162. Mykletun A., Overland S., Aaro L. E., Liabo H. M., Stewart R. Smoking in relation to anxiety and depression: Evidence from a large population survey: the HUNT study. Eur Psychiatry 2008; 23: 77–84.
163. Berg C. J., Wen H., Cummings J. R., Ahluwalia J. S., Druss B. G. Depression and substance abuse and dependency in relation to current smoking status and frequency of smoking among nondaily and daily smokers. Am J Addict 2013; 22: 581–589.